{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:20:24Z","timestamp":1769700024883,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Research Foundation (NRF) grants funded by the Korean government","award":["NRF-2019R1F1A1060878"],"award-info":[{"award-number":["NRF-2019R1F1A1060878"]}]},{"name":"National Research Foundation (NRF) grants funded by the Korean government","award":["NRF-2022R1F1A1071584"],"award-info":[{"award-number":["NRF-2022R1F1A1071584"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70494-4","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T05:02:43Z","timestamp":1724734963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Temporal trends and long-term outcomes of radiofrequency ablation for hepatocellular carcinoma within the Milan criteria"],"prefix":"10.1038","volume":"14","author":[{"given":"Se Young","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Oh","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Rim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hun Kyu","family":"Ryeom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Guen","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Kee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ae Jeong","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Young","family":"Tak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"70494_CR1","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL clinical practice guidelines: Management of hepatocellular carcinoma. J. Hepatol. 69(1) 182\u2013236 (2018)."},{"issue":"2","key":"70494_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jhep.2013.04.009","volume":"59","author":"A Cucchetti","year":"2013","unstructured":"Cucchetti, A. et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J. Hepatol. 59(2), 300\u2013307 (2013).","journal-title":"J. Hepatol."},{"issue":"3","key":"70494_CR3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s00330-006-0461-5","volume":"17","author":"D Choi","year":"2007","unstructured":"Choi, D. et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: Long-term results and prognostic factors in a large single-institution series. Eur. Radiol. 17(3), 684\u2013692 (2007).","journal-title":"Eur. Radiol."},{"issue":"1","key":"70494_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jhep.2012.09.020","volume":"58","author":"YS Kim","year":"2013","unstructured":"Kim, Y. S. et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J. Hepatol. 58(1), 89\u201397 (2013).","journal-title":"J. Hepatol."},{"issue":"3","key":"70494_CR5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1148\/radiol.2343040350","volume":"234","author":"R Lencioni","year":"2005","unstructured":"Lencioni, R. et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234(3), 961\u2013967 (2005).","journal-title":"Radiology"},{"issue":"11","key":"70494_CR6","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.ejso.2010.08.133","volume":"36","author":"ZW Peng","year":"2010","unstructured":"Peng, Z. W. et al. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: Long-term results. Eur. J. Surg. Oncol.: J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol. 36(11), 1054\u20131060 (2010).","journal-title":"Eur. J. Surg. Oncol.: J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"issue":"4","key":"70494_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/ajg.2011.425","volume":"107","author":"S Shiina","year":"2012","unstructured":"Shiina, S. et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am. J. Gastroenterol. 107(4), 569\u2013577 (2012).","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"70494_CR8","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1148\/radiol.13130940","volume":"270","author":"DH Lee","year":"2014","unstructured":"Lee, D. H. et al. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: Long-term results and prognostic factors in 162 patients with cirrhosis. Radiology 270(3), 900\u2013909 (2014).","journal-title":"Radiology"},{"issue":"5","key":"70494_CR9","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/hep.29321","volume":"66","author":"J Choi","year":"2017","unstructured":"Choi, J., Han, S., Kim, N. & Lim, Y. S. Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus-endemic population. Hepatology 66(5), 1454\u20131463 (2017).","journal-title":"Hepatology"},{"issue":"18","key":"70494_CR10","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/2012.jama.11975","volume":"308","author":"CY Wu","year":"2012","unstructured":"Wu, C. Y. et al. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 308(18), 1906\u20131914 (2012).","journal-title":"JAMA"},{"issue":"29","key":"70494_CR11","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1200\/JCO.2012.48.5896","volume":"31","author":"J Yin","year":"2013","unstructured":"Yin, J. et al. Effect of antiviral treatment with nucleotide\/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: A two-stage longitudinal clinical study. J. Clin. Oncol. 31(29), 3647\u20133655 (2013).","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"70494_CR12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/SLA.0000000000002727","volume":"268","author":"G Huang","year":"2018","unstructured":"Huang, G. et al. Antiviral therapy reduces hepatocellular carcinoma recurrence in patients with low HBV-DNA levels: A randomized controlled trial. Ann. Surg. 268(6), 943\u2013954 (2018).","journal-title":"Ann. Surg."},{"issue":"30","key":"70494_CR13","doi-asserted-by":"publisher","first-page":"47794","DOI":"10.18632\/oncotarget.10026","volume":"7","author":"W Sohn","year":"2016","unstructured":"Sohn, W. et al. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma. Oncotarget 7(30), 47794\u201347807 (2016).","journal-title":"Oncotarget"},{"issue":"1","key":"70494_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1148\/radiol.2016151243","volume":"280","author":"TW Kang","year":"2016","unstructured":"Kang, T. W. et al. Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus nonsubcapsular hepatocellular carcinoma: A propensity score matched study. Radiology 280(1), 300\u2013312 (2016).","journal-title":"Radiology"},{"issue":"2","key":"70494_CR15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1148\/radiol.2482071690","volume":"248","author":"S Sartori","year":"2008","unstructured":"Sartori, S. et al. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: A prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Radiology 248(2), 670\u2013679 (2008).","journal-title":"Radiology"},{"issue":"1","key":"70494_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1158\/1078-0432.CCR-16-2433","volume":"24","author":"WY Tak","year":"2018","unstructured":"Tak, W. Y. et al. Phase III HEAT study adding lyso-thermosensitive liposomal doxorubicin to radiofrequency ablation in patients with unresectable hepatocellular carcinoma lesions. Clin. Cancer Res. 24(1), 73\u201383 (2018).","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"70494_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2217\/hep-2016-0005","volume":"3","author":"R Lencioni","year":"2016","unstructured":"Lencioni, R. & Cioni, D. RFA plus lyso-thermosensitive liposomal doxorubicin: In search of the optimal approach to cure intermediate-size hepatocellular carcinoma. Hepat. Oncol. 3(3), 193\u2013200 (2016).","journal-title":"Hepat. Oncol."},{"issue":"6","key":"70494_CR18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","volume":"48","author":"N Afdhal","year":"2008","unstructured":"Afdhal, N. et al. Thrombocytopenia associated with chronic liver disease. J. Hepatol. 48(6), 1000\u20131007 (2008).","journal-title":"J. Hepatol."},{"issue":"5","key":"70494_CR19","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.20933","volume":"42","author":"J Bruix","year":"2005","unstructured":"Bruix, J. & Sherman, M. practice guidelines committee, american association for the study of liver diseases. Management of hepatocellular carcinoma. Hepatology 42(5), 1208\u20131236 (2005).","journal-title":"Hepatology"},{"issue":"4","key":"70494_CR20","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association For The Study Of The L, European Organisation For R, Treatment Of C","year":"2012","unstructured":"European Association For The Study Of The L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J. Hepatol. 56(4), 908\u2013943 (2012).","journal-title":"J. Hepatol."},{"issue":"10","key":"70494_CR21","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1097\/01.RVI.0000092666.72261.6B","volume":"14","author":"DS Lu","year":"2003","unstructured":"Lu, D. S. et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J. Vasc. Interv. Radiol. 14(10), 1267\u20131274 (2003).","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"3","key":"70494_CR22","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1148\/radiol.13130753","volume":"270","author":"TW Kang","year":"2014","unstructured":"Kang, T. W. et al. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: Retrospective comparison of long-term therapeutic outcomes. Radiology 270(3), 888\u2013899 (2014).","journal-title":"Radiology"},{"issue":"1","key":"70494_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jhep.2020.03.005","volume":"73","author":"N Kim","year":"2020","unstructured":"Kim, N. et al. Stereotactic body radiation therapy versus radiofrequency ablation in Asian patients with hepatocellular carcinoma. J. Hepatol. 73(1), 121\u2013129 (2020).","journal-title":"J. Hepatol."},{"key":"70494_CR24","volume-title":"Le Foie: Etudes Anatomiques et Chirurgicales","author":"C Couinaud","year":"1957","unstructured":"Couinaud, C., Delmas, A. & Patel, J. Le Foie: Etudes Anatomiques et Chirurgicales (Masson, 1957)."},{"issue":"1","key":"70494_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1148\/radiol.14132958","volume":"273","author":"M Ahmed","year":"2014","unstructured":"Ahmed, M. et al. Image-guided tumor ablation: Standardization of terminology and reporting criteria\u2014a 10-year update. Radiology 273(1), 241\u2013260 (2014).","journal-title":"Radiology"},{"issue":"4","key":"70494_CR26","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1007\/s00330-019-06575-0","volume":"30","author":"MW Lee","year":"2020","unstructured":"Lee, M. W. et al. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: Emphasis on association of local tumor progression and overall survival. Eur. Radiol. 30(4), 2391\u20132400 (2020).","journal-title":"Eur. Radiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70494-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70494-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70494-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T05:04:58Z","timestamp":1724735098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70494-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70494"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70494-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"15 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19815"}}